# Q10: Does cocoa flavanol supplementation slow cognitive aging?

Reviewed against the stricter bar in `.claude/CLAUDE.md` (see `question1.md`).

n=1 PMID.

**Current S/C/I**: 0 / 0 / 1
**Proposed S/C/I**: 0 / 0 / 1
**Net flips**: 0

---

## Confirmed (no change)

- `37840487` — COCOA RCT, n=55, 2-year multimodal lifestyle intervention.
  The intervention bundles **cocoa with diet, cognitive training,
  exercise, and remote coaching**. The Memory Performance Index improved
  in the intervention arm (2.1 [1.0] points, p=0.016). However, **the
  cocoa-specific contribution cannot be isolated** from the multimodal
  package. The note correctly identifies this. **inconclusive ✓**

## Cross-cutting issues

- **n=1 is too thin to be a useful eval.** A single PMID can't establish
  consensus on a question — there's no contradiction to detect. The
  retrieval/stance scoring numbers will be noisy at this corpus size.
- **The one PMID is a multimodal lifestyle study where cocoa is a minor
  component.** Even if positive, it doesn't speak directly to "cocoa
  flavanol slows cognitive aging." Stronger evidence (e.g., COSMOS-Mind,
  PMID 36218300, the 21,442-participant cocoa flavanol RCT) appears to
  be missing from the corpus or the relevant_pmids selection.
- **`expected_consensus: "mostly positive"`** is asserted but cannot be
  evaluated with n=1, especially when that one paper is multimodal.

## Recommendations

- **Either expand `relevant_pmids` for this question** with the major
  cocoa flavanol trials (COSMOS-Mind, COSMOS-Web, the Brigham/Harvard
  Mars-funded cohort papers), **or remove this question from the eval
  set.** As currently constituted Q10 contributes ~1% to retrieval
  precision/recall at maximum and provides no useful signal on stance
  accuracy.
- If retained, change the question to better match the available paper:
  *"Does multimodal lifestyle intervention improve cognition in early
  AD?"* — which would also let it migrate the `inconclusive` to
  `supports` (the COCOA trial primary outcome was significant for the
  multimodal intervention).

## Highest-confidence flips for this question

None. The single label is appropriate for the single paper. The real
issue is **corpus inadequacy**, not stance error.


---

## Abstracts (n=1)

Stance labels reflect the **proposed** stance after this review, annotated with `[FLIP from <prev>]` where changed.

### PMID 37840487 — current stance: `inconclusive`

**Golden note:** Remotely coached multimodal lifestyle intervention in AD — cocoa one of many components, can't isolate cocoa effect.

**A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.**

*Journal of Alzheimer's disease : JAD*, 2023. Types: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

> BACKGROUND: Comprehensive treatment of Alzheimer's disease and related dementias (ADRD) requires not only pharmacologic treatment but also management of existing medical conditions and lifestyle modifications including diet, cognitive training, and exercise. Personalized, multimodal therapies are needed to best prevent and treat Alzheimer's disease (AD). OBJECTIVE: The Coaching for Cognition in Alzheimer's (COCOA) trial was a prospective randomized controlled trial to test the hypothesis that a remotely coached multimodal lifestyle intervention would improve early-stage AD. METHODS: Participants with early-stage AD were randomized into two arms. Arm 1 (N = 24) received standard of care. Arm 2 (N = 31) additionally received telephonic personalized coaching for multiple lifestyle interventions. The primary outcome was a test of the hypothesis that the Memory Performance Index (MPI) change over time would be better in the intervention arm than in the control arm. The Functional Assessment Staging Test was assessed for a secondary outcome. COCOA collected psychometric, clinical, lifestyle, genomic, proteomic, metabolomic, and microbiome data at multiple timepoints (dynamic dense data) across two years for each participant. RESULTS: The intervention arm ameliorated 2.1 [1.0] MPI points (mean [SD], p = 0.016) compared to the control over the two-year intervention. No important adverse events or side effects were observed. CONCLUSION: Multimodal lifestyle interventions are effective for ameliorating cognitive decline and have a larger effect size than pharmacological interventions. Dietary changes and exercise are likely to be beneficial components of multimodal interventions in many individuals. Remote coaching is an effective intervention for early stage ADRD. Remote interventions were effective during the COVID pandemic.

---

